Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Tecan Group

Market Cap: CHF 2.4b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Gerresheimer

Market Cap: CHF 938.1m

Provides drug containment solutions in Germany and internationally.

Viatris

Market Cap: CHF 18.7b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: US$18.5b

Joincare Pharmaceutical Group Industry Co.,Ltd.

Bristol-Myers Squibb

Market Cap: CHF 138.1b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

AstraZeneca

Market Cap: CHF 187.5b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

BioMarin Pharmaceutical

Market Cap: CHF 13.4b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Novartis

Market Cap: CHF 240.1b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Jazz Pharmaceuticals

Market Cap: CHF 16.4b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Roche Holding

Market Cap: CHF 296.7b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Qiagen

Market Cap: CHF 9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Illumina

Market Cap: CHF 20.6b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Orion Oyj

Market Cap: CHF 11.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Roche Holding

Market Cap: CHF 296.7b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Sanofi

Market Cap: CHF 93.2b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Gilead Sciences

Market Cap: CHF 183.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Novavax

Market Cap: CHF 1.4b

A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.

Bayer

Market Cap: CHF 47.8b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Eli Lilly

Market Cap: CHF 1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Formycon

Market Cap: CHF 329.8m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Santhera Pharmaceuticals Holding

Market Cap: CHF 251.9m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

Idorsia

Market Cap: CHF 1.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.

Grifols

Market Cap: CHF 6.1b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

CSL

Market Cap: CHF 79.7b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Novartis

Market Cap: CHF 240.1b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Newron Pharmaceuticals

Market Cap: CHF 261.7m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Merck KGaA

Market Cap: CHF 60.2b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

CRISPR Therapeutics

Market Cap: CHF 5.8b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

MindMaze Therapeutics Holding

Market Cap: CHF 29.0m

Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.

Celldex Therapeutics

Market Cap: CHF 3.3b

A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.

Siegfried Holding

Market Cap: CHF 3.9b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Evotec

Market Cap: CHF 596.5m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Pfizer

Market Cap: CHF 161.0b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

MannKind

Market Cap: CHF 1.4b

A biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.

Kuros Biosciences

Market Cap: CHF 891.0m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Amgen

Market Cap: CHF 234.5b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.